Kaolin-activated whole blood thrombelastography (TEG) is an appealing test of coagulation in the perioperative period, because it assesses many aspects of coagulation and can be performed at the point of care. In this issue, Weinberg et al report the use of kaolin-activated TEG as a global assessment of coagulation as part of their investigation of coagulation activation after hepatic resection for cancer 1 . However, while kaolin-activated TEG assesses many aspects of coagulation, it does not assess all aspects of coagulation, so 'normal' findings should be interpreted with caution.
Firstly, the most important mechanism for coagulation activation in vivo is the interaction between circulating factor VII and tissue factor 2 , which is present in subendothelial tissue and exposed to plasma when vascular damage occurs. This is explained in the cell-based model of coagulation mentioned by Weinberg et al 1 . Unfortunately, standard TEG has no tissue factor (TF), so it cannot assess this fundamental aspect of coagulation activation. (Kaolin-activated TEG uses kaolin, not TF as the activator). In contrast, the prothrombin time (PT) specifically adds TF (to test the activities of factors II, VII, IX and X) 3 . It is therefore no surprise that the PT and TEG can provide different results. The question is, which is more likely to be correct about coagulation in vivo? Although we cannot be sure, it is more likely to be the PT, because kaolin-activated TEG does not assess the TF pathway. For this reason, 'normal' kaolinactivated TEGs should not be interpreted as 'proof' of normal coagulation, especially if a concurrent PT is abnormal. The need to consider conventional tests and the clinical picture is highlighted very sensibly by Weinberg et al in their conclusion.
Another reason to interpret 'normal' TEGs with caution is that standard kaolin-activated TEG cannot detect the effect of most antiplatelet drugs, most notably aspirin and clopidogrel 4 . This is because the thrombin generated in the TEG cup, which is mandatory for normal fibrin formation, activates platelets through a pathway independent of both cyclooxygenase and the platelet ADP receptor. In fact, kaolin-activated TEGs may appear normal despite a complete aspirin or clopidogrel effect. The only way to overcome this 'thrombin artifact' is to include a thrombin inhibitor in the TEG cup (e.g. heparin), and activate fibrin by the addition of batroxobin and factor XIII 5 . This option is available only through complex platelet mapping assays 5 . Therefore, 'normal' standard TEGs should not be used as evidence of 'normal' platelet function if aspirin or clopidogrel have been administered.
On the other hand, 'abnormal' TEGs may be very useful for the detection of a range of coagulation defects 6 . For example, there are few false positive 'hypocoagulable' TEG traces, other than those related to equipment or operator error (which are Hypocoagulability, hypercoagulability and the interpretation of 'normal' kaolin-activated thrombelastographs in the perioperative period The TEG is also particularly useful for the detection plasma hypercoagulability, which manifests as a shortened r time, increased alpha angle and increased maximal amplitude.
Conventional coagulation tests such as the PT and activated partial thromboplastin time change in one direction only (i.e. can be prolonged but not shortened). However, TEG variables can increase or decrease. A shortened TEG r time reflects an increase in procoagulant activity, an increased alpha angle reflects an increased rate of thrombin generation, and an increased maximal amplitude reflects greater interaction between fibrinogen and platelets 6 . These processes are a result of the complex physiological changes that occur in response to surgery or trauma (Figure 1 The study by Weinberg et al adds to our knowledge about the coagulation changes that occur postoperatively, both in relation to potential hypocoagulability and hypercoagulability. However, their findings add to the dilemmas faced by clinicians, not only because it is not possible to predict how individual patients will respond 1 , but also because different tests may provide opposite results. For this reason it is important to recognise the limitations of 'normal' TEGs, especially if conventional tests or the clinical picture suggest that coagulation is (or might be) abnormal. On the other hand, abnormal TEGs should not be overlooked, even if conventional tests or the clinical picture suggest otherwise.
n. M. gibbs Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Western Australia and Chief Editor, Anaesthesia and Intensive Care
